ABBOTT LABORATORIES
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
ABT$110.51+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheet
(dollars in millions)
| December 31 | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $7,616 | $6,896 |
| Investments, primarily bank time deposits and U.S. treasury bills | 351 | 383 |
| Trade receivables, less allowances of — 2024: $439; 2023: $444 | 6,925 | 6,565 |
| Inventories: | ||
| Finished products | 3,700 | 3,946 |
| Work in process | 840 | 807 |
| Materials | 1,654 | 1,817 |
| Total inventories | 6,194 | 6,570 |
| Other prepaid expenses and receivables | 2,570 | 2,256 |
| Total current assets | 23,656 | 22,670 |
| Investments | 886 | 799 |
| Property and equipment, at cost: | ||
| Land | 528 | 529 |
| Buildings | 4,207 | 4,161 |
| Equipment | 15,517 | 15,179 |
| Construction in progress | 2,488 | 2,064 |
| 22,740 | 21,933 | |
| Less: accumulated depreciation and amortization | 12,082 | 11,779 |
| Net property and equipment | 10,658 | 10,154 |
| Intangible assets, net of amortization | 6,647 | 8,815 |
| Goodwill | 23,108 | 23,679 |
| Deferred income taxes and other assets | 16,459 | 7,097 |
| $81,414 | $73,214 | |
(dollars in millions)
| December 31 | ||
|---|---|---|
| 2024 | 2023 | |
| Liabilities and Shareholders’ Investment | ||
| Current liabilities: | ||
| Trade accounts payable | $4,195 | $4,295 |
| Salaries, wages and commissions | 1,701 | 1,597 |
| Other accrued liabilities | 5,143 | 5,422 |
| Dividends payable | 1,024 | 955 |
| Income taxes payable | 594 | 492 |
| Current portion of long-term debt | 1,500 | 1,080 |
| Total current liabilities | 14,157 | 13,841 |
| Long-term debt | 12,625 | 13,599 |
| Post-employment obligations and other long-term liabilities | 6,731 | 6,947 |
| Commitments and contingencies | ||
| Shareholders’ investment: | ||
| Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued | — | — |
| Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2024: 1,991,472,630; 2023: 1,987,883,852 | 25,153 | 24,869 |
| Common shares held in treasury, at cost — Shares: 2024: 259,774,639; 2023: 253,807,494 | (16,844) | (15,981) |
| Earnings employed in the business | 47,261 | 37,554 |
| Accumulated other comprehensive income (loss) | (7,906) | (7,839) |
| Total Abbott Shareholders’ Investment | 47,664 | 38,603 |
| Noncontrolling interests in subsidiaries | 237 | 224 |
| Total Shareholders’ Investment | 47,901 | 38,827 |
| $81,414 | $73,214 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.